BaverstockK. F., PapworthD., VennartJ.: Risk of radiation at low dose rates. Lancet, 1; 430–433 (1981).
2.
BillrothT.: Die allgemeine chirurgische Pathologie und Therapie in 51 Vorlesungen; ein Handbuch fur Studirende und Ärzte, 14 Aufl. G. Reimer, Berlin1989.
HubbardG. W., WaneboH.: Defective suppressor cell activity in cancer patients. A defect in immune regulation. Cancer, 47; 2177–2184 (1981).
8.
LundC. C.: Second primary cancer in case of cancer of the buccal mucosa: mathematical study of susceptibility to cancer. N. Engl. J. Med., 209; 1144 (1933).
9.
LynchH. T., FollettK. L.: Family history in an oncology clinic: implications concerning cancer genetics. J.A.M.A., 242; 1268–1272 (1979).
10.
MoertelC. G.: Multiple primary malignant neoplasms, in: Recent results in cancer research, vol. 7, Springer-Verlag, Berlin1966.
11.
SchmidtW., PophamR. E.: The role of drinking and smoking in mortality from cancer in male alcoholics. Cancer, 47; 1031–1041 (1981).
12.
TsukudaY., MooreR. H.: Blood groups in patients with multiple cancer. Cancer, 17; 1229–1232 (1964).
13.
TwomeyP., SatalonaW., ChretienP.: Cellular immunity in cured cancer patients. Cancer, 33; 435–440 (1974).
14.
WaneboH.: Immunologic testing as a guide to cancer management. Surg. Clin. N. Amer., 59; 323–347 (1979).
15.
WarrenS., GatesO.: Multiple primary malignant tumors: a survey of the literature and a statistical study. Amer. J. Cancer, 16; 1358–1414 (1932).
16.
WilliamsR. R., HormM. S.: Association of cancer sites with tobacco and alcohol consumption and socioeconomic status of patients: interview study from the Third National Cancer Survey. J. Natl. Cancer Inst., 58; 525–547 (1977).
